Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA)

Historical Holders from Q4 2019 to Q3 2025

Symbol
CABA on Nasdaq
Type / Class
Equity / Common Stock, par value $0.00001 per share
Shares outstanding
96,015,846
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
71,298,009
Holdings value
$166,850,266
% of all portfolios
0.001%
Number of holders
75
Number of buys
34
Number of sells
-53
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JENNISON ASSOCIATES LLC 8.9% +24.3% $29,447,817 +$5,797,046 12,584,537 +24.5% Jennison Associates LLC 30 Sep 2025
PRUDENTIAL FINANCIAL INC 8.9% +21.4% $29,447,817 +$5,132,486 12,584,537 +21.1% PRUDENTIAL FINANCIAL INC 30 Sep 2025
T. Rowe Price Investment Management, Inc. 11.3% +24.4% $24,243,163 +$4,674,939 10,360,326 +23.9% T. Rowe Price Investment Management, Inc. 31 Oct 2025
Bain Capital Life Sciences Opportunities III, LP 9.99% $15,483,400 9,677,125 Bain Capital Life Sciences Opportunities III, LP 30 Jun 2025
Cormorant Asset Management, LP 9.99% +90.4% $22,445,240 +$10,745,240 9,591,983 +91.8% Cormorant Asset Management, LP 30 Sep 2025
Adage Capital Management, L.P. 9.99% $14,404,128 9,002,580 Adage Capital Management, L.P. 30 Jun 2025
Alyeska Investment Group, L.P. 6.03% -38.7% $13,572,000 -$7,264,219 5,800,000 -34.9% Alyeska Investment Group, L.P. 30 Sep 2025
VANGUARD GROUP INC 3.83% $5,245,105 3,450,727 The Vanguard Group 30 Jun 2025
CITADEL ADVISORS LLC 3.4% -36% $7,371,644 -$3,903,787 3,150,275 -34.6% Kenneth Griffin 30 Sep 2025
Nichtberger Steven 3.3% $4,855,198 3,034,499 Nichtberger Steven 30 Jun 2025
BlackRock, Inc. 1% -85.7% $1,359,774 -$3,803,722 894,647 -73.7% BlackRock, Inc. 30 Jun 2025

Institutional Holders of Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 71,298,009 $166,850,266 -$6,975,254 $2.34 75
2025 Q2 72,777,604 $110,698,611 +$55,724,802 $1.52 85
2025 Q1 36,304,416 $50,331,609 -$5,413,459 $1.38 91
2024 Q4 38,433,072 $87,226,012 -$42,983,423 $2.27 104
2024 Q3 48,049,164 $226,748,702 -$34,699,190 $4.72 116
2024 Q2 50,801,335 $379,995,301 -$32,124,100 $7.48 137
2024 Q1 51,050,542 $870,921,299 +$27,212,602 $17.06 157
2023 Q4 48,539,586 $1,101,850,659 +$176,650,504 $22.7 128
2023 Q3 40,903,546 $622,571,929 +$72,079,488 $15.22 97
2023 Q2 36,440,182 $470,450,874 +$156,067,581 $12.91 84
2023 Q1 24,651,946 $203,869,260 +$38,611,553 $8.27 70
2022 Q4 19,878,011 $183,868,921 +$77,826,088 $9.25 60
2022 Q3 11,928,226 $7,751,081 -$5,492,347 $0.6498 45
2022 Q2 16,803,742 $17,812,960 -$3,030,205 $1.06 48
2022 Q1 18,183,343 $36,877,990 -$1,968,981 $2.03 56
2021 Q4 18,168,410 $68,859,189 -$10,075,938 $3.79 60
2021 Q3 17,375,298 $211,265,514 +$20,553,121 $12.16 60
2021 Q2 15,752,840 $135,465,315 -$5,391,551 $8.6 60
2021 Q1 16,228,404 $180,131,214 +$595,907 $11.1 67
2020 Q4 16,173,259 $201,828,469 -$2,182,506 $12.48 54
2020 Q3 16,353,879 $177,273,014 -$991,132 $10.84 54
2020 Q2 16,442,959 $183,160,097 +$5,139,597 $11.14 51
2020 Q1 16,009,620 $116,871,000 -$3,057,830 $7.3 41
2019 Q4 16,265,458 $227,227,000 +$175,618,001 $13.97 40